$4.630
+0.975 (+21.05%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GLMD Prediction & Forecast by Similar Chart Analysis
Alphio's GLMD stock price prediction model matches the current Galmed Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.58 (-1.17%). The 1-week path is $4.68 (+1.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Galmed Pharmaceuticals Ltd Stock?
Galmed Pharmaceuticals Ltd is not a good buy right now due to its declining stock performance and negative financial indicators. The current price is $3.88, with a year-to-date change of -41.06% and a one-year change of -64.60%. Additionally, the company reported a last earnings EPS of -2.86, indicating ongoing losses. The RSI is at 33.289, suggesting the stock is oversold but may not recover soon given the persistent negative net income figures, such as -4,818,000 USD in Q4 2025. The main risk is the continued negative earnings trend, which has resulted in a forward P/E ratio of 0, indicating no earnings growth is expected in the near future.
GLMD stock price ended at $4.63 on Wednesday, after rising +21.05%
Galmed Pharmaceuticals Ltd (GLMD) last closed at $4.63, gaining +21.05%. These facts feed the 1-day and 1-week GLMD price prediction above.
Analyst Consensus
Galmed Pharmaceuticals Ltd (GLMD): 5 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Galmed Pharmaceuticals Ltd (GLMD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GLMD, ranked by similarity.
Seasonality analysis for GLMD
Historically the probability of a positive November return for GLMD is 0.00%. January offers the highest probability of a positive month at 26.23%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for GLMD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $2.02 | $2.21 | $2.36 | -52.27% |
| Dec 2026 | $2.00 | $2.21 | $2.24 | -52.27% |
In 2026, Galmed Pharmaceuticals Ltd (GLMD) is projected to range from $2.00 to $2.36.
Galmed Pharmaceuticals Ltd 2026 monthly forecast
In Nov 2026, Galmed Pharmaceuticals Ltd is projected to average $2.21, with a low of $2.02 and high of $2.36.
In Dec 2026, Galmed Pharmaceuticals Ltd is projected to average $2.21, with a low of $2.00 and high of $2.24.
Related articles
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
- Bitcoin Bear Market 2026: Why BTC Fell Below $70K and How Investors Can Manage Crypto RiskBitcoin is about 45% below its $126K peak as Fed hikes, 5% yields and ETF outflows bite. See how the 2026 bear market compares and how to manage crypto risk.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.